CANCER COMBINATION THERAPY INCLUDING A BCL-2 INHIBITOR Application WO-2024023279-A1 World Intellectual Property Organisation (WIPO) 01 Feb 2024
CANCER COMBINATION THERAPY INCLUDING A FLT3-INHIBITOR Application WO-2024023278-A1 World Intellectual Property Organisation (WIPO) 01 Feb 2024